纤维酸对与代谢功能障碍相关的脂肪性肝病的影响:全国多中心研究
Yasuyuki Komiyama1, Nobuharu Tamaki1, Keiji Tsuji2
1Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
JGH open : an open access journal of gastroenterology and hepatology
|September 11, 2025
概括
在患有代谢功能障碍相关的脂肪性肝病 (MASLD) 和高甘油三血症的患者中,纤维酸显著改善了肝功能. 氨酸氨基转移酶 (ALT) 水平和正常化率在三个月内得到改善,并持续了12个月.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题.
- 佩马菲布拉特是一种氧酶增殖器激活受体α (PPARα) 调节剂,用于过高甘油三血症.
- 在改善MASLD患者的肝功能中,纤维酸的疗效需要进一步评估.
研究的目的:
- 评估pemafibrate对MASLD患者肝功能的影响.
- 为了评估用pemafibrate治疗的MASLD患者的氨酸氨基转移酶 (ALT) 正常化率.
主要方法:
- 一项全国性的多中心队列研究包括352名患有MASLD和高甘油三血症的患者,这些患者开始服用pemafibrate.
- 主要结局是ALT正常化的速度 (ALT ≤30U/L).
- 实验室数据是在基线和开始后的3,6和12个月收集的.
主要成果:
- 平均ALT水平从基线时的60.1U/L显著下降到12个月后的38.1U/L (p < 0.001).
- 在12个月内,ALT正常化率从基线时的30.4%增加到56.6% (p < 0.001).
- 三个月后观察到显著改善,并在整个12个月的随访期间持续.
结论:
- 佩马纤维酸治疗显著改善ALT水平和正常化率在MASLD患者高甘油血症.
- 纤维酸的治疗效果在三个月内明显,持续长达12个月.
- 这项大规模研究提供了强有力的证据,证明pemafibrate是MASLD的潜在治疗选择.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
217
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
217
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
572
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
572
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
216
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
216
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K